Studies of transgenic mice showed that ANGPTL4 decreases blood glucose and improves glucose tolerance, at the same time, it induces hypertriglyceridemia and hepatic steatosis [19]. The gene discussed is ANGPTL4; the disease is hypertriglyceridemia.